Abstract: 1-[4-(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]piperazines with 2-pyrimidyl substituents in the 4- position have been synthesized and demonstrate useful anxiolytic properties. The compound 4,4-dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6-piperidinedi one, which has selective anxiolytic activity, constitutes the preferred embodiment of the invention.
Abstract: The novel compounds of the formula I are useful selective herbicides for postemergence application in crops of cereals, maize and rice.In formula I, ##STR1## A is an unsubstituted or substituted amino group, Q is a C.sub.2 -C.sub.6 alkylene bridge, Y is an oxygen or sulfur atom or an unsubstituted or substituted nitrogen atom, and Z is an unsubstituted or substituted phenyl, naphthyl or heterocyclic radical, which phenyl radical, containing the bridge member Y, can additionally carry one to four further substituents.
Type:
Grant
Filed:
May 22, 1981
Date of Patent:
November 1, 1983
Assignee:
Ciba-Geigy Corporation
Inventors:
Hans-Georg Brunner, Rolf Schurter, Henry Szczepanski
Abstract: 2-Thiohaloalkenyl-4-dialkoxyphosphino-thioyloxy-6-alkyl-1,3-pyrimidines represented by the formula: ##STR1## wherein R and R.sup.1 are independently lower alkyl; R.sup.2 is hydrogen, lower alkyl or lower alkoxy; X, Y and Z are independently halogen or hydrogen with at least one of X, Y and Z being halogen; possess fungicidal and insecticidal activity.
Abstract: Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.
Abstract: N-substituted haloalkyl apomorphines of the formula ##STR1## wherein R.sub.1 is hydrogen or R.sub.2 O; R.sub.2 is hydrogen, acyl, lower alkyl or ##STR2## R.sub.3 and R.sub.4 are lower alkyl; and X is halogen; and their acid addition salts. Representative compounds have neuroleptic properties.
Abstract: A process for protecting cultivated plants against aggressive agricultural chemicals is described in which oxime derivatives of the formula ##STR1## are used as antidotes. Either the cultivated area for the cultivated plants or the cultivated plants themselves or parts of the plant (seeds, tubers, stem parts and the like), as desired, can be treated with these oxime derivatives, which are used as a dressing.
Type:
Grant
Filed:
August 28, 1979
Date of Patent:
August 31, 1982
Assignee:
Ciba-Geigy Corporation
Inventors:
Alfons Lukaszczyk, Henry Martin, Peter J. Diel, Werner Fory, Karl Gatzi, Haukur Kristinsson, Beat Muller, Rene Muntwyler, Johannes P. Pachlatko, Hermann Rempfler, Rolf Schurter, Henry Szczepanski
Abstract: Alpha-[(lower alkylamino)alkyl]-4-hydroxy-3-(alkylthio, akylsulfinyl or alkylsulfonyl)benzenemethanols which have .beta.-adrenergic blocking activity and which are therefore useful in controlling tachycardia are prepared by reduction of the corresponding (lower alkylamino)alkyl 4-hydroxy-3-(akylthio, akylsulfinyl or alkylsulfonyl)phenyl ketones.
Abstract: A novel sensitive method for determining qualitatively and quantitatively the presence of a wide variety of physiologically active organic compounds (ligand) and their receptors is provided. The method employs a reagent which involves bonding a compound having structural similarity to the compound to be determined (ligand analog) to a fluorescing compound. The unknown compound is referred to as a ligand, the conjugate of the structurally similar compound and fluorescer is referred to as ligand analog-fluorescer, and compounds which recognize a specific structure and bind to such structure as referred to as receptors and are normally antibodies.The fluorescer which is chosen will have either a change is quantum yield or a change in its emission and/or absorption spectra or all of them, when bound to antibody, as compared to being unbound. For the purposes of the assay, all that is required is that there be a change in the emission intensity at some wavelength or band of wavelengths.
Abstract: Compounds useful as tracers in the radioimmunoassay of barbiturates: ##STR1## wherein (a) R.sub.1, R.sub.2 and R.sub.4 are identical to the substituents found at these positions in the barbiturate which is to be assayed;(b) at least one R.sub.3 is a radioiodinatable radical; and(c) if only one R.sub.3 is a radioiodinatable radical then the remaining R.sub.3 is identical to the substituent found at this position in the barbiturate which is to be assayed; and the radioiodinated derivatives of said compounds.
Type:
Grant
Filed:
June 12, 1978
Date of Patent:
January 13, 1981
Assignee:
Baxter Travenol Laboratories, Inc.
Inventors:
George H. Parsons, Jr., Ernest V. Groman
Abstract: Isoxazolo[3,4-d]pyrimidines of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 respectively, are hydrogen, lower alkyl, cycloalkyl, or aryl which may be substituted by halogen, are useful as antiinflammatory-analgesic drugs, and the industrially feasible production thereof is provided.
Type:
Grant
Filed:
March 30, 1977
Date of Patent:
December 12, 1978
Assignee:
Takeda Chemical Industries, Ltd.
Inventors:
Ryuji M. Marumoto, Yoshiyasu Furukawa, Kiyohisa Kawai
Abstract: A method is disclosed for the preparation of salts of monoesters of the carbonic acid, the improvement consisting in that the alcohols corresponding to the esters are reacted with carbon dioxide and a compound of an alkali metal or an alkaline earth metal. A distinct advantage over the use of the alcoholates is obtained inasmuch as the reaction is less violent, side-reactions are put aside and the costs are lowered.
Abstract: Compounds having the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sub.1 is alkoxycarbonyl, amido or substituted amido; R.sub.2 is acyl or sulfonyl; R.sub.3 is alkylamino, dialkylamino or a nitrogen containing heterocyclic group; A.sub.1 is an alkylene group having 2 to 5 carbon atoms; and n is 1, 2 or 3; have antiinflammatory activity.